You are here

SARC020

Completed
Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma
Type of Sarcoma: 
Advanced or Metastatic Untreated Soft Tissue Sarcoma
Drug: 
Trabectedin Infused to Doxorubicin
Accrual Status: 
Terminated
Overall Study Principal Investigator: 
James E. Butrynski, MD
Dana-Farber Cancer Institute

For more information about this trial and open sites: